InvestorsHub Logo
Followers 3
Posts 266
Boards Moderated 0
Alias Born 05/23/2016

Re: None

Monday, 06/27/2016 3:34:22 PM

Monday, June 27, 2016 3:34:22 PM

Post# of 30990
Maxim termination of coverage and Supreme Court ruling could pave the way for better days for RCPI!


Unanimous U.S. supreme Court decision could lead to more friendly FDA and open door for FDA approval and maybe even open door for J. Willams to return to RCPI.

FDA almost seemed against RCPI because of McDonnell case.. so now maybe they will welcome RCPI IND and FDA approval efforts

J. Williams may look at anatabine as his baby... might be far fetched but he might seek to return... provide alternative funding.. better legal team, etc.. to deal with criminal acts and torts by Maxim against company and shareholders as well as breach by note holders thru Maxim's agency.

Hopefully company acts swiftly on news to defend and enhance shareholder value, better negotiate with and/or sue convertible note holders for breach thru actions by Maxim and start moving towards FDA approval for anatabine citrate, not just for current announced testing, but also for anatabloc.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.